Progression of Renal Dysfunction in Patients with Cardiovascular Disease

Author(s): Yasunobu Hirata, Arihiro Kiyosue, Masao Takahashi, Hiroshi Satonaka, Daisuke Nagata, Masataka Sata, Etsu Suzuki, Ryozo Nagai

Journal Name: Current Cardiology Reviews

Volume 4 , Issue 3 , 2008

Become EABM
Become Reviewer


It has been established that patients with chronic kidney disease (CKD) suffer from frequent cardiovascular events. On the other hand, recent studies suggest that renal damage tends to worsen in patients with cardiovascular diseases (CVD). Although the mechanisms for the cardiorenal association are unclear, the presence of arteriosclerotic risk factors common to both CVD and CKD is important. In arteriosclerosis, vascular derangement progresses not only in the heart but also in the kidney. In addition, heart failure, cardiac catheterization and hesitation of medical treatments due to renal dysfunction may explain the progression of renal damage. Therefore, the goal of treatments is a total control of arteriosclerotic risk factors. Medication should be selected among agents with protective effects on both heart and kidney. It is important to always consider the presence of CKD for the treatment of the cardiovascular disease and strictly control the risk factors.

Keywords: CKD, angiotensin II, aldosterone, ARB, hypertension

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [198 - 202]
Pages: 5
DOI: 10.2174/157340308785160543
Price: $65

Article Metrics

PDF: 2